Patent · US Active

System and method for detecting amyloid proteins

US9220403B2 · kind B2 · utility

10Cited by
37References
43Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 12, 2011
Grant dateDec 29, 2015
Priority date
Expiry dateJun 28, 2032

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61B2562/0242
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

In accordance with an embodiment of the invention, there is provided a device and method for detecting an amyloid protein in an eye of a mammal. A method comprises illuminating the eye with a light source having at least one of a wavelength property, a polarization property or a combination thereof, each appropriate to produce fluorescence in at least an amyloid-binding compound when the amyloid-binding compound is bound to the amyloid protein, the amyloid-binding compound having been introduced to the eye and specifically binding to the amyloid protein indicative of the amyloidogenic disorder; and determining a time decay rate of fluorescence for at least the fluorescence produced by the amyloid-binding compound bound to the amyloid protein, the determining permitting distinguishing of the presence of the amyloid-binding compound bound to the amyloid protein in the eye based on at least the time decay rate.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.